Selected research
Market Structure
Global Vaccine Microneedle Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Vaccine Microneedle Patches market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Vaccine Microneedle Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Vaccine Microneedle Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vaccine Microneedle Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Vaccine Microneedle Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Vaccine Microneedle Patches include CosMED Pharmaceutical, Micron Biomedical, Raphas, VaxessTechnologies, Shenzhen Qinglan Biotechnology, WCC Biomedical and Zhuhai Youwe Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Vaccine Microneedle Patches market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vaccine Microneedle Patches and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vaccine Microneedle Patches sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vaccine Microneedle Patches market size, projected growth trends, production technologies, key applications, and end-use industries.
Vaccine Microneedle Patches Segment by Company
CosMED Pharmaceutical
Micron Biomedical
Raphas
VaxessTechnologies
Shenzhen Qinglan Biotechnology
WCC Biomedical
Zhuhai Youwe Biotechnology
Vaccine Microneedle Patches Segment by Type
Polymers Material
Silicon Material
Others
Vaccine Microneedle Patches Segment by Application
COVID-19 Vaccine
Enterovirus 71 Vaccine
Other Vaccines
Vaccine Microneedle Patches Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Microneedle Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Microneedle Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Microneedle Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vaccine Microneedle Patches market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Microneedle Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccine Microneedle Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vaccine Microneedle Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polymers Material
- Silicon Material
- Others
Applications
- COVID-19 Vaccine
- Enterovirus 71 Vaccine
- Other Vaccines
Companies covered
- CosMED Pharmaceutical
- Micron Biomedical
- Raphas
- VaxessTechnologies
- Shenzhen Qinglan Biotechnology
- WCC Biomedical
- Zhuhai Youwe Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Vaccine Microneedle Patches Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Vaccine Microneedle Patches Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Vaccine Microneedle Patches Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Vaccine Microneedle Patches Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Vaccine Microneedle Patches Market Dynamics
- 2.1 Vaccine Microneedle Patches Industry Trends
- 2.2 Vaccine Microneedle Patches Industry Drivers
- 2.3 Vaccine Microneedle Patches Industry Opportunities and Challenges
- 2.4 Vaccine Microneedle Patches Industry Restraints
3 Vaccine Microneedle Patches Market by Manufacturers
- 3.1 Global Vaccine Microneedle Patches Revenue by Manufacturers (2021-2026)
- 3.2 Global Vaccine Microneedle Patches Sales by Manufacturers (2021-2026)
- 3.3 Global Vaccine Microneedle Patches Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Vaccine Microneedle Patches Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vaccine Microneedle Patches Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Vaccine Microneedle Patches Manufacturers, Product Type & Application
- 3.7 Global Vaccine Microneedle Patches Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vaccine Microneedle Patches Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vaccine Microneedle Patches Players Market Share by Revenue in 2025
- 3.8.3 2025 Vaccine Microneedle Patches Tier 1, Tier 2, and Tier 3
4 Vaccine Microneedle Patches Market by Type
- 4.1 Vaccine Microneedle Patches Type Introduction
- 4.1.1 Polymers Material
- 4.1.2 Silicon Material
- 4.1.3 Others
- 4.2 Global Vaccine Microneedle Patches Sales by Type
- 4.2.1 Global Vaccine Microneedle Patches Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Vaccine Microneedle Patches Sales by Type (2021-2032)
- 4.2.3 Global Vaccine Microneedle Patches Sales Market Share by Type (2021-2032)
- 4.3 Global Vaccine Microneedle Patches Revenue by Type
- 4.3.1 Global Vaccine Microneedle Patches Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Vaccine Microneedle Patches Revenue by Type (2021-2032)
- 4.3.3 Global Vaccine Microneedle Patches Revenue Market Share by Type (2021-2032)
5 Vaccine Microneedle Patches Market by Application
- 5.1 Vaccine Microneedle Patches Application Introduction
- 5.1.1 COVID-19 Vaccine
- 5.1.2 Enterovirus 71 Vaccine
- 5.1.3 Other Vaccines
- 5.2 Global Vaccine Microneedle Patches Sales by Application
- 5.2.1 Global Vaccine Microneedle Patches Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Vaccine Microneedle Patches Sales by Application (2021-2032)
- 5.2.3 Global Vaccine Microneedle Patches Sales Market Share by Application (2021-2032)
- 5.3 Global Vaccine Microneedle Patches Revenue by Application
- 5.3.1 Global Vaccine Microneedle Patches Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Vaccine Microneedle Patches Revenue by Application (2021-2032)
- 5.3.3 Global Vaccine Microneedle Patches Revenue Market Share by Application (2021-2032)
6 Global Vaccine Microneedle Patches Sales by Region
- 6.1 Global Vaccine Microneedle Patches Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Vaccine Microneedle Patches Sales by Region (2021-2032)
- 6.2.1 Global Vaccine Microneedle Patches Sales by Region (2021-2026)
- 6.2.2 Global Vaccine Microneedle Patches Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Vaccine Microneedle Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Vaccine Microneedle Patches Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Vaccine Microneedle Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Vaccine Microneedle Patches Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Vaccine Microneedle Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Vaccine Microneedle Patches Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Vaccine Microneedle Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Vaccine Microneedle Patches Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Vaccine Microneedle Patches Revenue by Region
- 7.1 Global Vaccine Microneedle Patches Revenue by Region
- 7.1.1 Global Vaccine Microneedle Patches Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Vaccine Microneedle Patches Revenue by Region (2021-2026)
- 7.1.3 Global Vaccine Microneedle Patches Revenue by Region (2027-2032)
- 7.1.4 Global Vaccine Microneedle Patches Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Vaccine Microneedle Patches Revenue (2021-2032)
- 7.2.2 North America Vaccine Microneedle Patches Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Vaccine Microneedle Patches Revenue (2021-2032)
- 7.3.2 Europe Vaccine Microneedle Patches Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Vaccine Microneedle Patches Revenue (2021-2032)
- 7.4.2 Asia-Pacific Vaccine Microneedle Patches Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Vaccine Microneedle Patches Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Vaccine Microneedle Patches Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 CosMED Pharmaceutical
- 8.1.1 CosMED Pharmaceutical Company Information
- 8.1.2 CosMED Pharmaceutical Business Overview
- 8.1.3 CosMED Pharmaceutical Vaccine Microneedle Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 CosMED Pharmaceutical Vaccine Microneedle Patches Product Portfolio
- 8.1.5 CosMED Pharmaceutical Recent Developments
- 8.2 Micron Biomedical
- 8.2.1 Micron Biomedical Company Information
- 8.2.2 Micron Biomedical Business Overview
- 8.2.3 Micron Biomedical Vaccine Microneedle Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Micron Biomedical Vaccine Microneedle Patches Product Portfolio
- 8.2.5 Micron Biomedical Recent Developments
- 8.3 Raphas
- 8.3.1 Raphas Company Information
- 8.3.2 Raphas Business Overview
- 8.3.3 Raphas Vaccine Microneedle Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Raphas Vaccine Microneedle Patches Product Portfolio
- 8.3.5 Raphas Recent Developments
- 8.4 VaxessTechnologies
- 8.4.1 VaxessTechnologies Company Information
- 8.4.2 VaxessTechnologies Business Overview
- 8.4.3 VaxessTechnologies Vaccine Microneedle Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 VaxessTechnologies Vaccine Microneedle Patches Product Portfolio
- 8.4.5 VaxessTechnologies Recent Developments
- 8.5 Shenzhen Qinglan Biotechnology
- 8.5.1 Shenzhen Qinglan Biotechnology Company Information
- 8.5.2 Shenzhen Qinglan Biotechnology Business Overview
- 8.5.3 Shenzhen Qinglan Biotechnology Vaccine Microneedle Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Shenzhen Qinglan Biotechnology Vaccine Microneedle Patches Product Portfolio
- 8.5.5 Shenzhen Qinglan Biotechnology Recent Developments
- 8.6 WCC Biomedical
- 8.6.1 WCC Biomedical Company Information
- 8.6.2 WCC Biomedical Business Overview
- 8.6.3 WCC Biomedical Vaccine Microneedle Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 WCC Biomedical Vaccine Microneedle Patches Product Portfolio
- 8.6.5 WCC Biomedical Recent Developments
- 8.7 Zhuhai Youwe Biotechnology
- 8.7.1 Zhuhai Youwe Biotechnology Company Information
- 8.7.2 Zhuhai Youwe Biotechnology Business Overview
- 8.7.3 Zhuhai Youwe Biotechnology Vaccine Microneedle Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Zhuhai Youwe Biotechnology Vaccine Microneedle Patches Product Portfolio
- 8.7.5 Zhuhai Youwe Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Vaccine Microneedle Patches Value Chain Analysis
- 9.1.1 Vaccine Microneedle Patches Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Vaccine Microneedle Patches Production Mode & Process
- 9.2 Vaccine Microneedle Patches Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Vaccine Microneedle Patches Distributors
- 9.2.3 Vaccine Microneedle Patches Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst